New hope from <scp>OPERA</scp> trial for surgically fit rectal cancer patients who wish to have organ preservation-Reference-Cited by-同舟云学术

New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation

Published:2022-09 Issue:9 Volume:24 Page:1026-1027
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Disease

Author:

Myint Arthur Sun¹²

Affiliation:

1. Papillon Unit Clatterbridge Cancer Centre Liverpool UK

2. Department of Molecular and Clinical Medicine University of Liverpool Liverpool UK

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.16281

Reference8 articles.

1. Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: The 3-year results of OPERA randomized trial (NCT02505750).

2. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?

3. Low energy contact X ray brachytherapy (the Papillon technique) for early stage rectal cancer NICE 2015 (IPG 532). Available from:http://nice.org.uk/guidance/ipg532. Accessed 4 Aug 2022.

4. Thirty-day postoperative mortality after colorectal cancer surgery in England

5. NICE.Colorectal Guidelines (NG 151);2020. Available from:https://www.nice.org.uk/guidance/ng151/chapter/Recommendations#management‐of‐local‐disease. Accessed 4 Aug 2022.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it time for a paradigm shift in early rectal cancer treatment?;Annals of Oncology;2023-04

2. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives;Cancer Treatment Reviews;2023-01